Stengone Carmine N.

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-02-26	2026-02-25	Contineum Therapeutics Inc (CTNM)	PlS Planned sale	15,084 -2.5% 122.74 US$932,699	15,084 -2.5%	122.74	US$932,699
2026-02-26	2026-02-24	Contineum Therapeutics Inc (CTNM)	PlS Planned sale	98,177 -21.6% 230.91 US$2,298,143	98,177 -21.6%	230.91	US$2,298,143
2026-02-13	2026-02-11	Contineum Therapeutics Inc (CTNM)	PlS Planned sale	2,507 +37.6% 56.31 US$1,712,337	2,507 +37.6%	56.31	US$1,712,337
2026-02-11	2026-02-11	Contineum Therapeutics Inc (CTNM)	PrS Proposed sale	7,500 15.75 US$118,125	7,500	15.75	US$118,125
2024-09-12	2024-09-11	EyeGate Pharmaceuticals Inc (EYEG)	B Purchase	1,250 +inf% 3.68 US$4,600	1,250 +inf%	3.68	US$4,600